Manage Your Liver
Q:

Hep C News: Only heading in a new direction of treatment will help prevent deaths

Hep C News: Only heading in a new direction of treatment will help prevent deaths
A:

Recent data released by the Centre for Disease Control and Prevention (CDC) showed that the deaths associated with hepatitis C reached an all-time high of 19,659 in 2014. Since 2013, the annual hepatitis C-related mortality surpassed the total combined number of deaths from 60 other infectious diseases. [1]

 

Although the effectiveness of  the recently introduced hepatitis C antiviral treatment (DAA) is higher than previous drugs, this new treatment does not directly reduce liver damage nor improve liver health. [2] Together with the data released by CDC, it is suggested that the DAA treatments are not able to lower the number of deaths related to hepatitis C.

 

The only function of antiviral drugs is to eliminate the hepatitis virus in the human body, thus, to regain liver health, the liver must recover itself using its unique self-repairing ability. However using drugs actually causes further damage to the liver as the drug itself contains toxicity. A recent published paper has found that using DAA treatment might have an impact on the immune system as there is a sudden change of viral count, thus dramatically increasing the risk of liver cancer. [3] The number of related deaths caused by hepatitis C is continuously increasing; this is a clear indication that it is time to reconsider current treatment direction.

 

From the patients’ point of view, the primary objective of treatment should be to ensure normal liver function (ALT level), to reduce and prevent liver fibrosis, and to improve the quality of daily life. Only by successfully carrying out these objectives can one ensure long term liver health protection, reduce the likelihood of severe liver diseases and lower the risk of deaths caused by liver inflammation related diseases.

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Chronic liver disease is a serious condition and a leading cause of death among people across the world. The number of liver cancer cases have over took to become the leading cancer since 2014, and fatty liver disease/ NASH is set to become the leading cause of liver transplant in 2020. Protects your liver In the view of this, liver protection to prevent chronic liver disease is quickly becoming more important then ever. So what can we do
A:
ALT and AST are enzymes that are normally predominantly contained within liver cells. If the liver is injured or damaged, the liver cells spill these enzymes into the blood, raising the AST and ALT enzyme levels in the blood, and we can use it as a measurement of liver injury.   What are the differences between ALT and AST? AST is normally found in a variety of tissues including liver, heart, muscle, kidney, and the brain. It is released int
Hit Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us